Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis |
The Company’s assets and liabilities that were measured at fair value on a recurring basis were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measured as of March 31, 2022 |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
(In thousands) |
Assets |
|
|
|
|
|
|
|
Money market funds (i) |
$ |
104,352 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
104,352 |
|
U.S. Treasury securities (ii) |
43,471 |
|
|
— |
|
|
— |
|
|
43,471 |
|
Corporate bonds (ii) |
— |
|
|
38,254 |
|
|
— |
|
|
38,254 |
|
Total financial assets |
$ |
147,823 |
|
|
$ |
38,254 |
|
|
$ |
— |
|
|
$ |
186,077 |
|
Liabilities |
|
|
|
|
|
|
|
Common stock warrant liabilities (Public) (iii) |
$ |
18,285 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
18,285 |
|
Common stock warrant liabilities (Private Placement) (iii) |
— |
|
|
— |
|
|
9,434 |
|
|
9,434 |
|
Contingent earnout liabilities |
— |
|
|
— |
|
|
142,719 |
|
|
142,719 |
|
Total financial liabilities |
$ |
18,285 |
|
|
$ |
— |
|
|
$ |
152,153 |
|
|
$ |
170,438 |
|
|
|
|
|
|
|
|
|
|
Fair Value Measured as of December 31, 2021 |
|
Level 1 |
|
Level 2 |
|
Level 3 |
|
Total |
|
(In thousands) |
Assets |
|
|
|
|
|
|
|
Money market funds (i) |
$ |
207,471 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
207,471 |
|
U.S. Treasury securities (ii) |
8,141 |
|
|
— |
|
|
— |
|
|
8,141 |
|
Corporate bonds (ii) |
— |
|
|
7,342 |
|
|
— |
|
|
7,342 |
|
Total financial assets |
$ |
215,612 |
|
|
$ |
7,342 |
|
|
$ |
— |
|
|
$ |
222,954 |
|
Liabilities |
|
|
|
|
|
|
|
Common stock warrant liabilities (Public) (iii) |
$ |
14,318 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
14,318 |
|
Common stock warrant liabilities (Private Placement) (iii) |
— |
|
|
— |
|
|
7,387 |
|
|
7,387 |
|
Contingent earnout liabilities |
— |
|
|
— |
|
|
111,487 |
|
|
111,487 |
|
Total financial liabilities |
$ |
14,318 |
|
|
$ |
— |
|
|
$ |
118,874 |
|
|
$ |
133,192 |
|
(i) Included in cash and cash equivalents on the condensed consolidated balance sheets.
(ii) Included in short-term investments on the condensed consolidated balance sheets.
(iii) Included in warrant liabilities on the condensed consolidated balance sheets.
|
Summary of Changes in Fair Value of Level 3 Financial Instruments |
The following table presents a rollforward of the Level 3 assets and liabilities measured fair value on a recurring basis:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable convertible preferred stock warrant liabilities |
|
Private placement warrant liabilities |
|
Contingent earnout liabilities |
|
(In thousands) |
Fair value as of January 1, 2022 |
$ |
—
|
|
|
$ |
7,387
|
|
|
$ |
111,487
|
|
Change in fair value |
|
|
2,047 |
|
|
31,232 |
|
Fair value as of March 31, 2022 |
$ |
—
|
|
|
$ |
9,434
|
|
|
$ |
142,719
|
|
|
|
|
|
|
|
|
Redeemable convertible preferred stock warrant liabilities |
|
Private placement warrant liabilities |
|
Contingent earnout liabilities |
|
(In thousands) |
Fair value as of January 1, 2021 |
$ |
181
|
|
|
$ |
—
|
|
|
$ |
—
|
|
Change in fair value |
1,514 |
|
|
— |
|
|
— |
|
Fair value as of March 31, 2021 |
$ |
1,695
|
|
|
$ |
—
|
|
|
$ |
—
|
|
|